Search Results for: Pharmaceuticals

AstraZeneca-Oxford COVID vaccine trial volunteer dies in Brazil, tests to continue

Brazilian health authority Anvisa said that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.

Oct 22, 2020

Coronavirus vaccine update: US trial of AstraZeneca COVID vaccine may resume this week

AstraZeneca's large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company's UK trial fell ill with what was suspected to be a rare spinal inflammatory disorder called transverse myelitis.

Oct 21, 2020

India Inc expects steady recovery in Oct-Mar FY21: CII CEOs Poll

The business fraternity expects a steady recovery in the Indian economy during the second half of the financial year 2020-21, shows a poll of CEOs done by CII.

Oct 5, 2020

U.S. President Donald Trump speaks to reporters during a news conference inside the James S. Brady Briefing Room at the White House September 27, 2020 in Washington, U.S. REUTERS/Ken Cedeno

Trump's COVID timeline confusion; White House scramble to clarify

Americans were informed of Trump's illness only after midnight on Thursday, October 1. At 12.54 a.m. on October 2, Trump tweeted that he and the First Lady had tested positive.

Oct 4, 2020

PD Vaghela, IAS officer who helped in GST rollout, appointed as TRAI's new chairman

PD Vaghela replaces the current TRAI chief RS Sharma, who held the high post for five years.

Sep 28, 2020

India-Japan relations have progressed, FDI inflows spiked: Jaishankar

Japan's FDI in India is up to $3225 million in the FY 2019-20, from $2965 million in FY 2018-2019.

Sep 19, 2020

AstraZeneca resumes UK trials Of COVID vaccine earlier halted by patient illness

Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.

Sep 13, 2020

Panel to decide on AstraZeneca COVID vax trials after unexplained illness in UK

Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19 vaccine candidate.

Sep 10, 2020

AstraZeneca starts trial of COVID antibody treatment

British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.

Aug 25, 2020

Central Drugs Standard Control Organisation (CDSCO)

Digital Vision under DGCI scanner: Renaming Coldbest to Cofset AT cough syrup didn't help manufacturer

Cofset AT cough syrup, earlier sold as Coldbest in March 2019 is allegedly held responsible for causing renal failure, leading to deaths of nine children in the J&K earlier. DGCI orders nationwide halt on distribution and sales of Digital Vision's adulterated cough syrup.

Aug 10, 2020

Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment

Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that it is set to introduce a 400 mg version of oral antiviral - FabiFlu -- for the treatment of mild to moderate Covid-19 in India.

Aug 7, 2020

COVID-19 drug Favipiravir launched at ₹35 per tablet, cheapest available option

Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease.

Aug 5, 2020

India's Hetero wins approval to sell COVID drug favipiravir

India's Hetero Labs Ltd has received regulatory approval to sell its version of anti-viral drug favipiravir to treat COVID-19, the drugmaker said on Wednesday, as coronavirus infections in the world's third worst-hit nation crossed 1.5 million.

Jul 29, 2020

Kodak resurrected: Camera making firm forays into pharmaceutical biz amid Covid pandemic

Kodak has reportedly taken a loan of $765 million from the US International Development Finance Corporation to help its transition from Camera manufacturing company to pharma manufacturer.